Article info
PDFResearch paper
Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(α2–3)Gal
- Correspondence to Dr Ricard Rojas-Garcia, Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Sant Antoni Maria Claret 167, Barcelona 08025, Spain; rrojas{at}santpau.cat
Citation
Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(α2–3)Gal
Publication history
- Received May 18, 2009
- Revised July 13, 2009
- Accepted July 14, 2009
- First published September 2, 2009.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.